Decoy Therapeutics (DCOY) Other Operating Expenses (2016 - 2025)
Decoy Therapeutics (DCOY) posted quarterly Other Operating Expenses of $8.5 million for Q4 2025, up 1006.19% year-over-year from $770027.0 in Q4 2024, and up 1006.19% quarter-over-quarter from $770027.0 in Q4 2024.
Decoy Therapeutics (DCOY) Other Operating Expenses (2016 - 2025) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Other Operating Expenses for 6 consecutive years, with $8.5 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Operating Expenses rose 1006.19% year-over-year to $8.5 million; the TTM figure through Mar 2026 stood at $8.5 million (up 1006.19% YoY), while the FY2025 annual figure was $8.5 million, up 1006.19% from the prior year.
- Other Operating Expenses advanced to $8.5 million in Q4 2025 per DCOY's latest filing, from $770027.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $8.9 million in Q3 2022 and bottomed at $770027.0 in Q4 2024.
- Historically, Other Operating Expenses has averaged $6.1 million across 3 years, with a median of $8.5 million in 2025.
- On a YoY basis, Other Operating Expenses climbed as much as 1006.19% in 2025 and fell as far as 1006.19% in 2025.
- Decoy Therapeutics' Other Operating Expenses stood at $8.9 million in 2022, then sank by 91.31% to $770027.0 in 2024, then jumped by 1006.19% to $8.5 million in 2025.
- Business Quant data shows DCOY's Other Operating Expenses at $8.5 million in Q4 2025, $770027.0 in Q4 2024, and $8.9 million in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Decoy Therapeutics | 1.75 Mn | 1.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.52 Mn |
| Dec 31, 2024 | 770,027.00 |
| Sep 30, 2022 | 8.87 Mn |
| Dec 31, 2018 | 74,934.00 |
| Jun 30, 2018 | 179,945.00 |
| Mar 31, 2018 | 83,934.00 |
| Dec 31, 2017 | 133,343.00 |
| Sep 30, 2017 | 148,756.00 |
| Jun 30, 2017 | 145,325.00 |
| Mar 31, 2017 | 79,106.00 |
| Dec 31, 2016 | 133,706.00 |
| Sep 30, 2016 | 221,090.00 |
| Jun 30, 2016 | 110,931.00 |
| Mar 31, 2016 | 197,020.00 |